GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gcm2
|
ENSRNOG00000015008 | glial cells missing homolog 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Gcm2 | rn6_v1_chr17_+_21490402_21490402 | 0.51 | 1.7e-22 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_78707861 | 136.52 |
ENSRNOT00000091927
|
Ppp2r2c
|
protein phosphatase 2, regulatory subunit B, gamma |
chr14_-_86297623 | 134.39 |
ENSRNOT00000067162
ENSRNOT00000081607 ENSRNOT00000085265 |
Camk2b
|
calcium/calmodulin-dependent protein kinase II beta |
chr3_-_11382004 | 71.94 |
ENSRNOT00000047921
ENSRNOT00000064039 |
Dnm1
|
dynamin 1 |
chr14_+_77380262 | 69.39 |
ENSRNOT00000008030
|
Nsg1
|
neuron specific gene family member 1 |
chr1_-_73753128 | 66.58 |
ENSRNOT00000068459
|
Ttyh1
|
tweety family member 1 |
chr8_+_49441106 | 61.03 |
ENSRNOT00000030152
|
Scn4b
|
sodium voltage-gated channel beta subunit 4 |
chr6_+_92229686 | 58.48 |
ENSRNOT00000046085
|
Atl1
|
atlastin GTPase 1 |
chr8_-_116893057 | 56.80 |
ENSRNOT00000082113
|
Bsn
|
bassoon (presynaptic cytomatrix protein) |
chr8_-_59226597 | 56.33 |
ENSRNOT00000088208
|
Acsbg1
|
acyl-CoA synthetase bubblegum family member 1 |
chr5_+_140870140 | 52.34 |
ENSRNOT00000074347
|
Hpcal4
|
hippocalcin-like 4 |
chr19_+_41482728 | 50.91 |
ENSRNOT00000022943
|
Calb2
|
calbindin 2 |
chr18_+_79406381 | 49.51 |
ENSRNOT00000022303
ENSRNOT00000058295 ENSRNOT00000058296 ENSRNOT00000022280 |
Mbp
|
myelin basic protein |
chr10_-_15166457 | 48.55 |
ENSRNOT00000026676
|
Metrn
|
meteorin, glial cell differentiation regulator |
chr17_+_47397558 | 47.99 |
ENSRNOT00000085923
|
Epdr1
|
ependymin related 1 |
chr18_+_27632786 | 47.97 |
ENSRNOT00000073564
ENSRNOT00000078969 |
Reep2
|
receptor accessory protein 2 |
chr17_-_27969433 | 46.57 |
ENSRNOT00000073967
|
Nrn1
|
neuritin 1 |
chr1_-_81881549 | 44.64 |
ENSRNOT00000027497
|
Atp1a3
|
ATPase Na+/K+ transporting subunit alpha 3 |
chr1_-_103256823 | 44.54 |
ENSRNOT00000018860
|
Ptpn5
|
protein tyrosine phosphatase, non-receptor type 5 |
chr2_+_198721724 | 44.13 |
ENSRNOT00000043535
|
Ankrd34a
|
ankyrin repeat domain 34A |
chr20_-_1980101 | 43.71 |
ENSRNOT00000084582
ENSRNOT00000085050 ENSRNOT00000082545 ENSRNOT00000088396 |
Gabbr1
|
gamma-aminobutyric acid type B receptor subunit 1 |
chr10_-_18574710 | 43.47 |
ENSRNOT00000079031
|
Kcnip1
|
potassium voltage-gated channel interacting protein 1 |
chr17_-_18592750 | 43.22 |
ENSRNOT00000065742
|
Cap2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr11_+_75905443 | 43.15 |
ENSRNOT00000002650
|
Fgf12
|
fibroblast growth factor 12 |
chr7_+_141346398 | 43.04 |
ENSRNOT00000077175
|
Asic1
|
acid sensing ion channel subunit 1 |
chr10_-_18574909 | 42.92 |
ENSRNOT00000083090
|
Kcnip1
|
potassium voltage-gated channel interacting protein 1 |
chr13_-_82753438 | 42.77 |
ENSRNOT00000075948
|
Atp1b1
|
ATPase Na+/K+ transporting subunit beta 1 |
chr4_-_157078130 | 41.76 |
ENSRNOT00000015570
|
Clstn3
|
calsyntenin 3 |
chr3_-_168033457 | 40.47 |
ENSRNOT00000055111
|
Bcas1
|
breast carcinoma amplified sequence 1 |
chr16_-_79973735 | 39.77 |
ENSRNOT00000057845
ENSRNOT00000086896 |
Dlgap2
|
DLG associated protein 2 |
chr12_+_14021727 | 39.30 |
ENSRNOT00000060608
|
Mmd2
|
monocyte to macrophage differentiation-associated 2 |
chr9_-_82477136 | 38.92 |
ENSRNOT00000026753
ENSRNOT00000089555 |
Resp18
|
regulated endocrine-specific protein 18 |
chr13_+_77485113 | 38.61 |
ENSRNOT00000080254
|
Tnr
|
tenascin R |
chr3_-_102151489 | 38.59 |
ENSRNOT00000006349
|
Ano3
|
anoctamin 3 |
chr1_-_198454914 | 38.35 |
ENSRNOT00000049044
|
Prrt2
|
proline-rich transmembrane protein 2 |
chr14_+_60764409 | 38.23 |
ENSRNOT00000005168
|
Lgi2
|
leucine-rich repeat LGI family, member 2 |
chr1_+_266952561 | 37.75 |
ENSRNOT00000076452
|
Neurl1
|
neuralized E3 ubiquitin protein ligase 1 |
chr1_+_81372650 | 36.88 |
ENSRNOT00000088829
|
Zfp428
|
zinc finger protein 428 |
chr5_-_105582375 | 36.79 |
ENSRNOT00000083373
|
Slc24a2
|
solute carrier family 24 member 2 |
chr19_+_56220755 | 36.21 |
ENSRNOT00000023452
|
Tubb3
|
tubulin, beta 3 class III |
chr12_+_47551935 | 36.15 |
ENSRNOT00000056932
|
RGD1560398
|
RGD1560398 |
chr3_-_176816114 | 35.83 |
ENSRNOT00000079262
ENSRNOT00000018697 |
Stmn3
|
stathmin 3 |
chr10_-_61361250 | 35.54 |
ENSRNOT00000092203
|
Rap1gap2
|
RAP1 GTPase activating protein 2 |
chr3_+_177225737 | 35.33 |
ENSRNOT00000045845
|
Oprl1
|
opioid related nociceptin receptor 1 |
chr2_+_143475323 | 35.24 |
ENSRNOT00000044028
ENSRNOT00000015437 |
Trpc4
|
transient receptor potential cation channel, subfamily C, member 4 |
chr3_+_113319456 | 35.14 |
ENSRNOT00000051354
|
Ckmt1
|
creatine kinase, mitochondrial 1 |
chr5_+_128501847 | 34.95 |
ENSRNOT00000010645
|
Rab3b
|
RAB3B, member RAS oncogene family |
chr2_+_115678344 | 34.90 |
ENSRNOT00000036717
|
Slc7a14
|
solute carrier family 7, member 14 |
chr16_+_20691978 | 34.89 |
ENSRNOT00000038139
ENSRNOT00000082319 |
Tmem59l
|
transmembrane protein 59-like |
chr4_-_89151184 | 34.83 |
ENSRNOT00000010263
|
Nap1l5
|
nucleosome assembly protein 1-like 5 |
chrX_-_39956841 | 34.79 |
ENSRNOT00000050708
|
Klhl34
|
kelch-like family member 34 |
chr3_+_51687809 | 34.32 |
ENSRNOT00000087242
|
Scn2a
|
sodium voltage-gated channel alpha subunit 2 |
chr19_-_56311991 | 34.15 |
ENSRNOT00000014090
|
Dbndd1
|
dysbindin domain containing 1 |
chr1_-_212548730 | 33.98 |
ENSRNOT00000089729
|
Caly
|
calcyon neuron-specific vesicular protein |
chr3_-_105279462 | 33.33 |
ENSRNOT00000010679
|
Scg5
|
secretogranin V |
chr7_-_119441487 | 32.97 |
ENSRNOT00000067635
|
Pvalb
|
parvalbumin |
chr1_+_214927172 | 32.91 |
ENSRNOT00000027134
|
Brsk2
|
BR serine/threonine kinase 2 |
chr8_-_40023193 | 32.37 |
ENSRNOT00000014404
|
Nrgn
|
neurogranin |
chr4_+_22859622 | 32.32 |
ENSRNOT00000073501
ENSRNOT00000068410 |
Adam22
|
ADAM metallopeptidase domain 22 |
chr8_-_58542844 | 32.29 |
ENSRNOT00000012041
|
Elmod1
|
ELMO domain containing 1 |
chr14_+_17534412 | 32.24 |
ENSRNOT00000079304
ENSRNOT00000046771 |
Cdkl2
|
cyclin dependent kinase like 2 |
chr10_-_63952726 | 32.13 |
ENSRNOT00000090461
|
Doc2b
|
double C2 domain beta |
chr14_+_6994190 | 32.12 |
ENSRNOT00000020357
|
Sparcl1
|
SPARC like 1 |
chr15_-_37410848 | 32.10 |
ENSRNOT00000081757
|
Gjb6
|
gap junction protein, beta 6 |
chr5_+_164972480 | 31.77 |
ENSRNOT00000012670
|
Fbxo2
|
F-box protein 2 |
chr7_+_139698148 | 31.43 |
ENSRNOT00000078579
|
Pfkm
|
phosphofructokinase, muscle |
chr3_+_117416345 | 31.26 |
ENSRNOT00000056054
|
Ctxn2
|
cortexin 2 |
chr7_-_29701586 | 30.99 |
ENSRNOT00000009084
ENSRNOT00000089269 |
Ano4
|
anoctamin 4 |
chr4_-_71713063 | 30.95 |
ENSRNOT00000059447
|
Fam131b
|
family with sequence similarity 131, member B |
chr3_+_177226417 | 30.73 |
ENSRNOT00000031328
|
Oprl1
|
opioid related nociceptin receptor 1 |
chr12_+_48316143 | 30.52 |
ENSRNOT00000084511
|
Svop
|
SV2 related protein |
chr16_+_21061237 | 30.27 |
ENSRNOT00000092136
|
Ncan
|
neurocan |
chr16_+_67350539 | 30.12 |
ENSRNOT00000085659
ENSRNOT00000015879 |
Unc5d
|
unc-5 netrin receptor D |
chr9_-_55673704 | 30.06 |
ENSRNOT00000066231
ENSRNOT00000081677 |
Tmeff2
|
transmembrane protein with EGF-like and two follistatin-like domains 2 |
chr14_-_3389943 | 30.00 |
ENSRNOT00000037101
|
Ephx4
|
epoxide hydrolase 4 |
chr15_+_52148379 | 29.81 |
ENSRNOT00000074912
|
Phyhip
|
phytanoyl-CoA 2-hydroxylase interacting protein |
chr7_-_117151256 | 29.72 |
ENSRNOT00000078846
|
Nrbp2
|
nuclear receptor binding protein 2 |
chr13_+_90692666 | 29.69 |
ENSRNOT00000010028
|
Igsf8
|
immunoglobulin superfamily, member 8 |
chr2_+_144646308 | 29.59 |
ENSRNOT00000078337
ENSRNOT00000093407 |
Dclk1
|
doublecortin-like kinase 1 |
chr5_+_103479767 | 29.34 |
ENSRNOT00000008999
|
Sh3gl2
|
SH3 domain-containing GRB2-like 2 |
chr1_+_125367280 | 29.28 |
ENSRNOT00000022049
|
Apba2
|
amyloid beta precursor protein binding family A member 2 |
chr1_+_72860218 | 29.19 |
ENSRNOT00000024547
|
Syt5
|
synaptotagmin 5 |
chr10_+_80790168 | 28.83 |
ENSRNOT00000073315
ENSRNOT00000075163 |
Car10
|
carbonic anhydrase 10 |
chr18_+_73564247 | 28.83 |
ENSRNOT00000077679
ENSRNOT00000035317 |
St8sia5
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
chr8_+_56179816 | 28.64 |
ENSRNOT00000059078
|
Arhgap20
|
Rho GTPase activating protein 20 |
chr8_-_98738446 | 28.62 |
ENSRNOT00000019860
|
Zic1
|
Zic family member 1 |
chr13_-_52197205 | 28.52 |
ENSRNOT00000009712
|
Shisa4
|
shisa family member 4 |
chr3_+_58632476 | 28.48 |
ENSRNOT00000010630
|
Rapgef4
|
Rap guanine nucleotide exchange factor 4 |
chr4_+_35279063 | 28.17 |
ENSRNOT00000011833
|
Nxph1
|
neurexophilin 1 |
chr2_+_121165137 | 27.96 |
ENSRNOT00000016236
|
Sox2
|
SRY box 2 |
chr10_+_39655455 | 27.95 |
ENSRNOT00000058817
|
Acsl6
|
acyl-CoA synthetase long-chain family member 6 |
chr16_-_21089508 | 27.85 |
ENSRNOT00000072565
|
Hapln4
|
hyaluronan and proteoglycan link protein 4 |
chr4_-_108008484 | 27.56 |
ENSRNOT00000007971
|
Ctnna2
|
catenin alpha 2 |
chr10_+_92191718 | 27.53 |
ENSRNOT00000006764
ENSRNOT00000032941 |
Crhr1
|
corticotropin releasing hormone receptor 1 |
chr1_-_42587666 | 27.50 |
ENSRNOT00000083225
ENSRNOT00000025355 |
Rgs17
|
regulator of G-protein signaling 17 |
chr3_+_110574417 | 27.49 |
ENSRNOT00000031231
|
Disp2
|
dispatched RND transporter family member 2 |
chr4_-_4473307 | 27.32 |
ENSRNOT00000045773
|
Dpp6
|
dipeptidyl peptidase like 6 |
chr17_-_48562838 | 27.24 |
ENSRNOT00000017102
ENSRNOT00000084702 |
Amph
|
amphiphysin |
chr2_+_228544418 | 27.22 |
ENSRNOT00000013030
|
Tram1l1
|
translocation associated membrane protein 1-like 1 |
chr4_-_146016325 | 26.89 |
ENSRNOT00000067931
|
Atp2b2
|
ATPase plasma membrane Ca2+ transporting 2 |
chr1_+_36185916 | 26.73 |
ENSRNOT00000041762
|
Ube2ql1
|
ubiquitin-conjugating enzyme E2Q family-like 1 |
chr16_-_59366824 | 26.46 |
ENSRNOT00000015062
|
RGD1304810
|
similar to 6430573F11Rik protein |
chr9_+_82647071 | 26.39 |
ENSRNOT00000027135
|
Asic4
|
acid sensing ion channel subunit family member 4 |
chr7_-_126461658 | 26.25 |
ENSRNOT00000081032
|
Wnt7b
|
wingless-type MMTV integration site family, member 7B |
chr18_+_31094965 | 26.22 |
ENSRNOT00000026526
|
Rell2
|
RELT-like 2 |
chr7_-_141185710 | 26.21 |
ENSRNOT00000085033
|
Faim2
|
Fas apoptotic inhibitory molecule 2 |
chr2_-_172459165 | 26.10 |
ENSRNOT00000057473
|
Schip1
|
schwannomin interacting protein 1 |
chr1_+_256955652 | 26.08 |
ENSRNOT00000020411
|
Lgi1
|
leucine-rich, glioma inactivated 1 |
chr19_+_6046665 | 26.07 |
ENSRNOT00000084126
|
Cdh8
|
cadherin 8 |
chr4_-_147163467 | 25.97 |
ENSRNOT00000010748
|
Timp4
|
tissue inhibitor of metalloproteinase 4 |
chr12_+_41073824 | 25.90 |
ENSRNOT00000001844
|
Rph3a
|
rabphilin 3A |
chr4_-_179307095 | 25.82 |
ENSRNOT00000021193
|
Bcat1
|
branched chain amino acid transaminase 1 |
chr14_+_66631690 | 25.50 |
ENSRNOT00000079658
|
Kcnip4
|
potassium voltage-gated channel interacting protein 4 |
chr9_-_44237117 | 25.46 |
ENSRNOT00000068496
|
RGD1310819
|
similar to putative protein (5S487) |
chr4_-_64330996 | 25.38 |
ENSRNOT00000016088
|
Ptn
|
pleiotrophin |
chr13_+_101181994 | 25.25 |
ENSRNOT00000052407
|
Susd4
|
sushi domain containing 4 |
chrX_+_23081125 | 25.23 |
ENSRNOT00000071639
|
AABR07037520.1
|
|
chr5_-_40237591 | 25.21 |
ENSRNOT00000011393
|
Fut9
|
fucosyltransferase 9 |
chr14_+_8182383 | 25.10 |
ENSRNOT00000092719
|
Mapk10
|
mitogen activated protein kinase 10 |
chrX_+_17171605 | 25.07 |
ENSRNOT00000048236
|
Nudt10
|
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
chr1_+_78029555 | 25.00 |
ENSRNOT00000047289
|
Slc8a2
|
solute carrier family 8 member A2 |
chrX_+_105134498 | 24.89 |
ENSRNOT00000002058
|
Tmem35
|
transmembrane protein 35 |
chr3_-_52447622 | 24.89 |
ENSRNOT00000083552
|
Scn1a
|
sodium voltage-gated channel alpha subunit 1 |
chr6_+_79254339 | 24.75 |
ENSRNOT00000073970
|
Sstr1
|
somatostatin receptor 1 |
chr6_+_83083740 | 24.47 |
ENSRNOT00000007600
|
Lrfn5
|
leucine rich repeat and fibronectin type III domain containing 5 |
chr10_+_102136283 | 24.27 |
ENSRNOT00000003735
|
Sstr2
|
somatostatin receptor 2 |
chr1_-_88908750 | 24.20 |
ENSRNOT00000028297
|
Aplp1
|
amyloid beta precursor like protein 1 |
chr9_+_17841410 | 24.17 |
ENSRNOT00000031706
|
Tmem151b
|
transmembrane protein 151B |
chr1_-_220502272 | 23.87 |
ENSRNOT00000041238
|
Klc2
|
kinesin light chain 2 |
chr4_+_438668 | 23.83 |
ENSRNOT00000008951
|
En2
|
engrailed homeobox 2 |
chr3_+_56861396 | 23.72 |
ENSRNOT00000000008
ENSRNOT00000084375 |
Gad1
|
glutamate decarboxylase 1 |
chr5_-_82168347 | 23.72 |
ENSRNOT00000084959
ENSRNOT00000084147 |
Astn2
|
astrotactin 2 |
chr2_+_220298245 | 23.70 |
ENSRNOT00000022625
|
Plppr4
|
phospholipid phosphatase related 4 |
chr12_-_35979193 | 23.68 |
ENSRNOT00000071104
|
Tmem132b
|
transmembrane protein 132B |
chr18_-_86878142 | 23.60 |
ENSRNOT00000058139
|
Dok6
|
docking protein 6 |
chrX_+_62727755 | 23.54 |
ENSRNOT00000077055
|
Pcyt1b
|
phosphate cytidylyltransferase 1, choline, beta |
chr3_+_48106099 | 23.50 |
ENSRNOT00000007218
|
Slc4a10
|
solute carrier family 4 member 10 |
chr8_+_56179637 | 23.31 |
ENSRNOT00000035989
|
Arhgap20
|
Rho GTPase activating protein 20 |
chr12_-_22680630 | 23.30 |
ENSRNOT00000041808
|
Vgf
|
VGF nerve growth factor inducible |
chr13_+_67351087 | 23.27 |
ENSRNOT00000003567
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2 |
chrX_+_39711201 | 23.26 |
ENSRNOT00000080512
ENSRNOT00000009802 |
Cnksr2
|
connector enhancer of kinase suppressor of Ras 2 |
chr2_+_115337439 | 23.08 |
ENSRNOT00000015779
|
Eif5a2
|
eukaryotic translation initiation factor 5A2 |
chr8_-_117382715 | 23.02 |
ENSRNOT00000027466
|
P4htm
|
prolyl 4-hydroxylase, transmembrane |
chr13_+_84474319 | 23.00 |
ENSRNOT00000031367
ENSRNOT00000072244 ENSRNOT00000072897 ENSRNOT00000064168 ENSRNOT00000074954 ENSRNOT00000073696 |
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr2_+_27905535 | 22.84 |
ENSRNOT00000022120
|
Fam169a
|
family with sequence similarity 169, member A |
chr14_-_78377825 | 22.81 |
ENSRNOT00000068104
|
AABR07015812.1
|
|
chr8_+_118333706 | 22.67 |
ENSRNOT00000028278
|
Cspg5
|
chondroitin sulfate proteoglycan 5 |
chr2_-_198184739 | 22.64 |
ENSRNOT00000028751
|
Vps45
|
vacuolar protein sorting 45 |
chr1_-_52544450 | 22.62 |
ENSRNOT00000043474
|
Pde10a
|
phosphodiesterase 10A |
chr16_-_7007287 | 22.58 |
ENSRNOT00000041216
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr8_-_84632817 | 22.50 |
ENSRNOT00000076942
|
Mlip
|
muscular LMNA-interacting protein |
chr20_+_7279820 | 22.48 |
ENSRNOT00000090820
|
Pacsin1
|
protein kinase C and casein kinase substrate in neurons 1 |
chr20_+_5815837 | 22.48 |
ENSRNOT00000036999
|
Lhfpl5
|
lipoma HMGIC fusion partner-like 5 |
chr10_+_75055020 | 22.44 |
ENSRNOT00000010755
|
Tspoap1
|
TSPO associated protein 1 |
chr12_-_10391270 | 21.99 |
ENSRNOT00000092340
|
Wasf3
|
WAS protein family, member 3 |
chr3_-_147849875 | 21.87 |
ENSRNOT00000081153
|
Nrsn2
|
neurensin 2 |
chr6_+_107596782 | 21.80 |
ENSRNOT00000076882
|
Dnal1
|
dynein, axonemal, light chain 1 |
chr8_+_65611570 | 21.71 |
ENSRNOT00000017147
|
Larp6
|
La ribonucleoprotein domain family, member 6 |
chr16_-_7007051 | 21.65 |
ENSRNOT00000023984
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr11_+_86512797 | 21.65 |
ENSRNOT00000051680
|
Gp1bb
|
glycoprotein Ib platelet beta subunit |
chr5_-_170679315 | 21.63 |
ENSRNOT00000071459
|
Ajap1
|
adherens junctions associated protein 1 |
chr5_-_109651730 | 21.53 |
ENSRNOT00000093032
|
Elavl2
|
ELAV like RNA binding protein 2 |
chr6_+_26797126 | 21.46 |
ENSRNOT00000010586
|
Cgref1
|
cell growth regulator with EF hand domain 1 |
chr2_-_188561267 | 21.45 |
ENSRNOT00000089781
ENSRNOT00000092093 |
Trim46
|
tripartite motif-containing 46 |
chr9_-_114619711 | 21.44 |
ENSRNOT00000050012
|
Mtcl1
|
microtubule crosslinking factor 1 |
chr5_+_139790395 | 21.43 |
ENSRNOT00000015033
|
Rims3
|
regulating synaptic membrane exocytosis 3 |
chr16_+_20297414 | 21.39 |
ENSRNOT00000025576
|
Slc5a5
|
solute carrier family 5 member 5 |
chr12_-_29743705 | 21.24 |
ENSRNOT00000001185
|
Caln1
|
calneuron 1 |
chr10_-_103340922 | 21.04 |
ENSRNOT00000004191
|
Btbd17
|
BTB domain containing 17 |
chr10_+_58342393 | 21.03 |
ENSRNOT00000010358
|
Wscd1
|
WSC domain containing 1 |
chr7_-_72328128 | 21.02 |
ENSRNOT00000008227
|
Tspyl5
|
TSPY-like 5 |
chr6_-_98157087 | 21.01 |
ENSRNOT00000013275
|
Kcnh5
|
potassium voltage-gated channel subfamily H member 5 |
chr5_-_138267601 | 20.99 |
ENSRNOT00000008726
|
Tmem269
|
transmembrane protein 269 |
chr13_-_80379929 | 20.96 |
ENSRNOT00000067653
ENSRNOT00000075938 |
Dnm3
|
dynamin 3 |
chr16_+_54765325 | 20.85 |
ENSRNOT00000065327
ENSRNOT00000086899 |
Mtmr7
|
myotubularin related protein 7 |
chrX_+_127562660 | 20.75 |
ENSRNOT00000029031
ENSRNOT00000010367 |
Gria3
|
glutamate ionotropic receptor AMPA type subunit 3 |
chr14_-_82055290 | 20.64 |
ENSRNOT00000058062
|
RGD1560394
|
RGD1560394 |
chr8_-_91338843 | 20.56 |
ENSRNOT00000012999
|
Elovl4
|
ELOVL fatty acid elongase 4 |
chrX_+_157150655 | 20.50 |
ENSRNOT00000090795
|
Pnck
|
pregnancy up-regulated nonubiquitous CaM kinase |
chr4_-_43096399 | 20.49 |
ENSRNOT00000087167
|
Cttnbp2
|
cortactin binding protein 2 |
chr4_-_55407922 | 20.47 |
ENSRNOT00000031714
|
Grm8
|
glutamate metabotropic receptor 8 |
chr4_+_168976859 | 20.38 |
ENSRNOT00000068663
|
Fam234b
|
family with sequence similarity 234, member B |
chr15_-_47442664 | 20.31 |
ENSRNOT00000072994
|
Prss55
|
protease, serine, 55 |
chr1_-_125967756 | 20.30 |
ENSRNOT00000031488
|
Fam189a1
|
family with sequence similarity 189, member A1 |
chr10_-_51576376 | 20.27 |
ENSRNOT00000004829
|
Arhgap44
|
Rho GTPase activating protein 44 |
chr8_-_47094352 | 20.26 |
ENSRNOT00000048347
|
Grik4
|
glutamate ionotropic receptor kainate type subunit 4 |
chr7_+_141326950 | 20.15 |
ENSRNOT00000084075
|
Asic1
|
acid sensing ion channel subunit 1 |
chrX_+_106523278 | 20.06 |
ENSRNOT00000070802
|
MGC109340
|
similar to Microsomal signal peptidase 23 kDa subunit (SPase 22 kDa subunit) (SPC22/23) |
chr5_+_146337491 | 20.00 |
ENSRNOT00000029395
|
LOC100912566
|
UPF0500 protein C1orf216 homolog |
chr7_-_13751271 | 19.90 |
ENSRNOT00000009931
|
Slc1a6
|
solute carrier family 1 member 6 |
chr6_+_97110158 | 19.85 |
ENSRNOT00000088430
|
Syt16
|
synaptotagmin 16 |
chr12_+_28381982 | 19.78 |
ENSRNOT00000076101
|
Wbscr17
|
Williams-Beuren syndrome chromosome region 17 |
chr10_-_36322356 | 19.72 |
ENSRNOT00000000248
|
Zfp354c
|
zinc finger protein 354C |
chr2_-_96668222 | 19.64 |
ENSRNOT00000016567
|
Pkia
|
cAMP-dependent protein kinase inhibitor alpha |
chr1_-_263269762 | 19.64 |
ENSRNOT00000022309
|
Got1
|
glutamic-oxaloacetic transaminase 1 |
chr18_+_62852303 | 19.64 |
ENSRNOT00000087673
|
Gnal
|
G protein subunit alpha L |
chr10_+_59585072 | 19.64 |
ENSRNOT00000025009
|
Camkk1
|
calcium/calmodulin-dependent protein kinase kinase 1 |
chr8_+_82288705 | 19.58 |
ENSRNOT00000012409
|
Bcl2l10
|
BCL2 like 10 |
chr5_-_85123829 | 19.48 |
ENSRNOT00000007578
|
Brinp1
|
BMP/retinoic acid inducible neural specific 1 |
chr10_+_55940533 | 19.47 |
ENSRNOT00000012061
|
RGD1563441
|
similar to RIKEN cDNA A030009H04 |
chr11_+_34598492 | 19.35 |
ENSRNOT00000065600
|
Ttc3
|
tetratricopeptide repeat domain 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
44.8 | 134.4 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
16.5 | 66.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
16.5 | 49.5 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) positive regulation of metalloendopeptidase activity(GO:1904685) |
15.2 | 91.3 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
14.3 | 42.8 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
13.3 | 92.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
13.2 | 79.1 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
11.6 | 69.6 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
11.3 | 56.3 | GO:0001552 | ovarian follicle atresia(GO:0001552) |
10.2 | 61.2 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
9.3 | 27.9 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
9.2 | 27.5 | GO:0051867 | general adaptation syndrome, behavioral process(GO:0051867) |
9.2 | 55.0 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
9.0 | 63.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
8.9 | 151.5 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
8.8 | 35.0 | GO:1904373 | response to kainic acid(GO:1904373) |
8.7 | 26.2 | GO:0072054 | renal outer medulla development(GO:0072054) |
8.7 | 35.0 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
8.6 | 43.2 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
8.6 | 25.8 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
8.4 | 25.3 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
7.9 | 31.4 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
7.8 | 23.3 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
7.4 | 44.5 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
7.1 | 28.5 | GO:1901423 | response to benzene(GO:1901423) |
7.0 | 28.0 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
6.5 | 19.6 | GO:0006532 | fumarate metabolic process(GO:0006106) aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) |
6.3 | 19.0 | GO:0002086 | diaphragm contraction(GO:0002086) |
6.3 | 37.7 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
6.3 | 25.1 | GO:1901908 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
6.1 | 60.9 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
6.0 | 6.0 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
5.9 | 23.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
5.9 | 52.8 | GO:0071436 | sodium ion export(GO:0071436) |
5.8 | 17.4 | GO:0021629 | muscle attachment(GO:0016203) olfactory nerve morphogenesis(GO:0021627) olfactory nerve structural organization(GO:0021629) |
5.8 | 17.3 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
5.7 | 17.0 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
5.7 | 17.0 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
5.5 | 71.9 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
5.5 | 33.2 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
5.3 | 48.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) sensory perception of sweet taste(GO:0050916) |
5.3 | 42.6 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
5.2 | 15.7 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
5.2 | 15.5 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
5.2 | 15.5 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
5.1 | 15.2 | GO:1900453 | negative regulation of long term synaptic depression(GO:1900453) |
5.0 | 15.1 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
5.0 | 30.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
4.9 | 24.3 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
4.8 | 14.5 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
4.7 | 18.8 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
4.6 | 13.9 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
4.6 | 18.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
4.6 | 13.8 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
4.6 | 18.4 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
4.5 | 45.2 | GO:0046710 | GDP metabolic process(GO:0046710) |
4.5 | 17.8 | GO:0043179 | rhythmic excitation(GO:0043179) |
4.4 | 26.6 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
4.3 | 13.0 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
4.3 | 21.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
4.2 | 29.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
4.1 | 20.6 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
4.1 | 16.3 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
4.0 | 83.5 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
4.0 | 51.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
3.9 | 11.8 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
3.9 | 11.6 | GO:1904708 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) granulosa cell apoptotic process(GO:1904700) regulation of granulosa cell apoptotic process(GO:1904708) |
3.8 | 23.1 | GO:0045901 | regulation of translational termination(GO:0006449) positive regulation of translational elongation(GO:0045901) |
3.8 | 11.5 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
3.8 | 19.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
3.8 | 3.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
3.8 | 56.9 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
3.7 | 29.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
3.7 | 11.0 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
3.6 | 3.6 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
3.6 | 18.2 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
3.6 | 18.1 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
3.6 | 17.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
3.6 | 14.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
3.5 | 10.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
3.5 | 14.2 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
3.5 | 59.2 | GO:0045760 | positive regulation of action potential(GO:0045760) |
3.4 | 20.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
3.4 | 61.0 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
3.4 | 13.5 | GO:0033227 | dsRNA transport(GO:0033227) |
3.4 | 13.5 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
3.3 | 36.4 | GO:0099612 | protein localization to axon(GO:0099612) |
3.3 | 13.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
3.3 | 9.8 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
3.2 | 26.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
3.2 | 32.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
3.2 | 16.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
3.1 | 9.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
3.0 | 30.5 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
3.0 | 9.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
3.0 | 59.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
2.9 | 29.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
2.9 | 11.6 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
2.9 | 31.8 | GO:0006465 | signal peptide processing(GO:0006465) |
2.9 | 17.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
2.9 | 23.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.9 | 8.6 | GO:0051977 | lysophospholipid transport(GO:0051977) |
2.9 | 14.3 | GO:0035934 | corticosterone secretion(GO:0035934) |
2.9 | 5.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
2.8 | 19.6 | GO:0009405 | pathogenesis(GO:0009405) |
2.8 | 25.0 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
2.8 | 11.1 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
2.8 | 11.1 | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
2.8 | 5.5 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
2.8 | 13.8 | GO:0006868 | glutamine transport(GO:0006868) |
2.7 | 13.6 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
2.7 | 13.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
2.7 | 2.7 | GO:0097324 | melanocyte migration(GO:0097324) |
2.6 | 5.2 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
2.6 | 23.5 | GO:1904116 | response to vasopressin(GO:1904116) |
2.6 | 10.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
2.6 | 7.8 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.6 | 147.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
2.6 | 28.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.5 | 10.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
2.5 | 22.7 | GO:0015705 | iodide transport(GO:0015705) |
2.5 | 7.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
2.5 | 7.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
2.5 | 24.6 | GO:0060013 | righting reflex(GO:0060013) |
2.4 | 19.3 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
2.4 | 4.8 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
2.4 | 16.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
2.4 | 11.8 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
2.3 | 9.4 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
2.3 | 35.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
2.3 | 14.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
2.3 | 9.2 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
2.3 | 18.4 | GO:0015808 | L-alanine transport(GO:0015808) |
2.3 | 11.5 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
2.3 | 6.9 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
2.3 | 16.0 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
2.3 | 4.6 | GO:0051012 | microtubule sliding(GO:0051012) |
2.3 | 6.8 | GO:0006382 | adenosine to inosine editing(GO:0006382) regulation of RNA interference(GO:1900368) |
2.3 | 25.0 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
2.3 | 4.5 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
2.2 | 4.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
2.1 | 34.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
2.1 | 6.3 | GO:0010070 | zygote asymmetric cell division(GO:0010070) |
2.1 | 4.2 | GO:0035607 | ventricular zone neuroblast division(GO:0021847) fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) |
2.1 | 6.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.1 | 33.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
2.0 | 26.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.0 | 6.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
2.0 | 16.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
2.0 | 8.0 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
2.0 | 4.0 | GO:0021836 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
1.9 | 5.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.9 | 17.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.9 | 20.7 | GO:0007614 | short-term memory(GO:0007614) |
1.9 | 26.2 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
1.9 | 7.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.9 | 16.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
1.9 | 20.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.9 | 3.7 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
1.9 | 5.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.9 | 20.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.9 | 5.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.8 | 9.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
1.8 | 9.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
1.8 | 16.4 | GO:0042756 | drinking behavior(GO:0042756) |
1.8 | 5.4 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
1.8 | 16.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.8 | 70.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
1.8 | 10.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.7 | 8.7 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
1.7 | 29.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
1.7 | 51.6 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.7 | 49.8 | GO:0060292 | long term synaptic depression(GO:0060292) |
1.7 | 18.6 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
1.7 | 6.7 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
1.7 | 6.7 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
1.7 | 23.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.7 | 19.9 | GO:0001964 | startle response(GO:0001964) |
1.6 | 1.6 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
1.6 | 21.0 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
1.6 | 41.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.6 | 8.0 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.6 | 6.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.6 | 117.4 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
1.6 | 4.7 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.5 | 3.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.5 | 6.1 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.5 | 19.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.5 | 4.5 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) fatty-acyl-CoA catabolic process(GO:0036115) |
1.5 | 1.5 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
1.5 | 31.5 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
1.5 | 12.0 | GO:0060717 | chorion development(GO:0060717) |
1.5 | 16.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.5 | 14.8 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.5 | 2.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.5 | 13.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.4 | 7.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) response to hypobaric hypoxia(GO:1990910) |
1.4 | 4.3 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
1.4 | 15.8 | GO:1990403 | embryonic brain development(GO:1990403) |
1.4 | 7.1 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.4 | 4.3 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.4 | 7.1 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
1.4 | 7.1 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.4 | 11.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
1.4 | 5.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
1.3 | 4.0 | GO:0019541 | acetate metabolic process(GO:0006083) propionate metabolic process(GO:0019541) |
1.3 | 36.2 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
1.3 | 23.3 | GO:0043084 | penile erection(GO:0043084) |
1.3 | 3.9 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
1.3 | 25.5 | GO:0008210 | estrogen metabolic process(GO:0008210) |
1.3 | 17.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
1.3 | 1.3 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
1.3 | 10.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.2 | 15.0 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.2 | 5.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
1.2 | 17.2 | GO:0036065 | fucosylation(GO:0036065) |
1.2 | 4.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.2 | 2.4 | GO:0051866 | general adaptation syndrome(GO:0051866) |
1.2 | 8.4 | GO:0006598 | polyamine catabolic process(GO:0006598) |
1.2 | 6.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) |
1.2 | 2.4 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
1.2 | 21.3 | GO:0010107 | potassium ion import(GO:0010107) |
1.2 | 7.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.2 | 4.7 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
1.2 | 18.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
1.2 | 2.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.1 | 26.1 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
1.1 | 10.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
1.1 | 7.9 | GO:0033572 | transferrin transport(GO:0033572) |
1.1 | 4.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.1 | 10.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.1 | 3.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
1.1 | 11.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
1.1 | 7.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.1 | 4.4 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
1.1 | 3.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.1 | 16.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.1 | 16.4 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
1.1 | 2.2 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
1.1 | 3.3 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
1.1 | 1.1 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
1.1 | 3.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.0 | 3.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
1.0 | 55.0 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
1.0 | 3.0 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
1.0 | 11.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
1.0 | 8.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
1.0 | 43.8 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
1.0 | 7.8 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
1.0 | 49.5 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
1.0 | 2.9 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.0 | 2.9 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.0 | 10.6 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
1.0 | 12.5 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
1.0 | 5.7 | GO:0032264 | IMP salvage(GO:0032264) |
0.9 | 2.8 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.9 | 2.8 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
0.9 | 6.5 | GO:1901374 | acetate ester transport(GO:1901374) |
0.9 | 3.7 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.9 | 13.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.9 | 0.9 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.9 | 20.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.9 | 19.9 | GO:0097503 | sialylation(GO:0097503) |
0.9 | 5.4 | GO:0016559 | peroxisome fission(GO:0016559) |
0.9 | 9.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.9 | 2.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.9 | 3.5 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.9 | 4.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.9 | 6.1 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
0.9 | 3.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.8 | 11.0 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.8 | 7.5 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.8 | 5.8 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.8 | 51.6 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.8 | 2.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.8 | 6.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.8 | 6.6 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.8 | 47.9 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.8 | 21.7 | GO:1990138 | neuron projection extension(GO:1990138) |
0.8 | 2.4 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.8 | 4.8 | GO:0090385 | regulation of lysosomal lumen pH(GO:0035751) phagosome-lysosome fusion(GO:0090385) |
0.8 | 2.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.8 | 12.5 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.8 | 8.6 | GO:0071625 | vocalization behavior(GO:0071625) |
0.8 | 23.2 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.8 | 10.0 | GO:0042407 | cristae formation(GO:0042407) |
0.8 | 1.5 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) spermine acetylation(GO:0032919) |
0.8 | 1.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.7 | 5.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.7 | 4.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.7 | 2.2 | GO:0006788 | heme oxidation(GO:0006788) |
0.7 | 2.1 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.7 | 3.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.7 | 5.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.7 | 10.4 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.7 | 34.5 | GO:0046847 | filopodium assembly(GO:0046847) |
0.7 | 4.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.7 | 17.7 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.7 | 2.7 | GO:0031179 | peptide modification(GO:0031179) |
0.7 | 2.7 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.7 | 2.0 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.7 | 0.7 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.6 | 21.4 | GO:0021762 | substantia nigra development(GO:0021762) |
0.6 | 3.8 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.6 | 1.9 | GO:1900095 | random inactivation of X chromosome(GO:0060816) regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.6 | 4.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.6 | 1.9 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) GDP-L-fucose metabolic process(GO:0046368) |
0.6 | 16.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.6 | 4.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.6 | 25.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.6 | 6.2 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.6 | 5.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.6 | 1.8 | GO:0070947 | neutrophil mediated killing of gram-positive bacterium(GO:0070946) neutrophil mediated killing of fungus(GO:0070947) |
0.6 | 2.4 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.6 | 2.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.6 | 1.8 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.6 | 25.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.6 | 8.9 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.6 | 8.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 18.0 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.6 | 10.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.6 | 2.9 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.6 | 15.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.6 | 8.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.6 | 21.6 | GO:0031103 | axon regeneration(GO:0031103) |
0.6 | 1.1 | GO:0007418 | ventral midline development(GO:0007418) |
0.6 | 20.2 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.6 | 5.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.6 | 2.8 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.6 | 23.7 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.5 | 2.7 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.5 | 17.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.5 | 11.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.5 | 9.7 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.5 | 9.1 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.5 | 3.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.5 | 1.6 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.5 | 4.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.5 | 2.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.5 | 6.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.5 | 5.5 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.5 | 34.1 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.5 | 45.1 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.5 | 2.0 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
0.5 | 3.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.5 | 6.8 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.5 | 15.0 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.5 | 7.1 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.5 | 6.6 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.5 | 36.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.5 | 9.6 | GO:0048588 | developmental cell growth(GO:0048588) |
0.5 | 2.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 2.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.4 | 3.0 | GO:0032288 | myelin assembly(GO:0032288) |
0.4 | 1.3 | GO:0035128 | post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
0.4 | 12.7 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.4 | 2.1 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.4 | 4.6 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.4 | 4.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.4 | 2.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 2.0 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.4 | 1.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.4 | 1.6 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.4 | 12.6 | GO:0051693 | actin filament capping(GO:0051693) |
0.4 | 3.1 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.4 | 6.9 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.4 | 3.0 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 12.8 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.4 | 0.7 | GO:1990839 | response to endothelin(GO:1990839) cellular response to endothelin(GO:1990859) |
0.4 | 2.2 | GO:0034184 | positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.4 | 31.2 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.4 | 2.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.4 | 14.0 | GO:0007416 | synapse assembly(GO:0007416) |
0.4 | 15.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.4 | 1.4 | GO:0052314 | phytoalexin metabolic process(GO:0052314) |
0.3 | 1.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 0.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.3 | 1.7 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 2.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 11.7 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.3 | 1.7 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 1.0 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.3 | 2.3 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.3 | 1.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 3.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 5.9 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.3 | 1.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.3 | 2.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.3 | 0.9 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.3 | 1.8 | GO:0015874 | norepinephrine transport(GO:0015874) norepinephrine secretion(GO:0048243) |
0.3 | 17.0 | GO:0022900 | electron transport chain(GO:0022900) |
0.3 | 2.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 0.9 | GO:0031989 | bombesin receptor signaling pathway(GO:0031989) |
0.3 | 2.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 7.0 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.3 | 0.8 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.3 | 2.2 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.3 | 2.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.3 | 10.2 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.3 | 1.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 2.0 | GO:1904869 | protein localization to nuclear body(GO:1903405) positive regulation of establishment of protein localization to telomere(GO:1904851) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.3 | 2.3 | GO:0006198 | cAMP catabolic process(GO:0006198) cyclic nucleotide catabolic process(GO:0009214) |
0.3 | 14.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 23.8 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.2 | 1.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 1.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 1.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 17.4 | GO:0008361 | regulation of cell size(GO:0008361) |
0.2 | 0.2 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 3.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.2 | 4.1 | GO:0031577 | mitotic spindle assembly checkpoint(GO:0007094) spindle checkpoint(GO:0031577) spindle assembly checkpoint(GO:0071173) mitotic spindle checkpoint(GO:0071174) |
0.2 | 2.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 3.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 2.8 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 1.7 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 0.6 | GO:0006431 | methionyl-tRNA aminoacylation(GO:0006431) |
0.2 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 1.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 5.0 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.2 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 1.3 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 1.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 6.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.2 | 7.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 3.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.2 | 26.3 | GO:0007409 | axonogenesis(GO:0007409) |
0.2 | 1.9 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.2 | 3.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 3.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 1.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 3.2 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 1.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 1.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 5.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 3.3 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.1 | 4.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 6.6 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 1.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 1.3 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.3 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) farnesyl diphosphate metabolic process(GO:0045338) |
0.1 | 1.1 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.1 | 6.5 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.1 | 2.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 1.9 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.2 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.1 | 2.0 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.8 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.4 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.7 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.0 | 0.6 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.0 | 0.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 46.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 1.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.0 | GO:0016598 | protein arginylation(GO:0016598) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.8 | 74.4 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
14.6 | 43.7 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
13.9 | 69.4 | GO:0098845 | postsynaptic endosome(GO:0098845) |
13.3 | 66.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
13.1 | 65.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
10.5 | 31.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
9.8 | 58.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
9.7 | 48.7 | GO:0072534 | perineuronal net(GO:0072534) |
9.4 | 65.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
8.3 | 49.5 | GO:0033269 | internode region of axon(GO:0033269) |
7.9 | 23.7 | GO:0060187 | cell pole(GO:0060187) |
7.8 | 38.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
6.7 | 53.3 | GO:0044327 | dendritic spine head(GO:0044327) |
6.1 | 18.4 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
6.0 | 120.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
5.7 | 28.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
5.6 | 151.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
5.3 | 31.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
4.9 | 19.4 | GO:0097427 | microtubule bundle(GO:0097427) |
4.8 | 19.2 | GO:0045298 | tubulin complex(GO:0045298) |
4.6 | 161.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
4.5 | 27.0 | GO:0097441 | basilar dendrite(GO:0097441) |
4.5 | 44.8 | GO:1990635 | proximal dendrite(GO:1990635) |
4.3 | 17.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
3.9 | 42.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
3.7 | 18.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
3.4 | 10.2 | GO:1990923 | PET complex(GO:1990923) |
3.4 | 20.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
3.4 | 67.1 | GO:0043196 | varicosity(GO:0043196) |
3.3 | 45.8 | GO:0043083 | synaptic cleft(GO:0043083) |
3.2 | 19.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
3.1 | 86.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
3.0 | 26.9 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
2.8 | 14.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
2.7 | 24.3 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
2.7 | 43.0 | GO:0005883 | neurofilament(GO:0005883) |
2.6 | 7.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
2.6 | 10.3 | GO:0097196 | Shu complex(GO:0097196) |
2.5 | 7.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
2.4 | 64.1 | GO:0043204 | perikaryon(GO:0043204) |
2.2 | 6.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
2.2 | 8.7 | GO:0044308 | axonal spine(GO:0044308) |
2.1 | 6.4 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
2.1 | 6.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
2.1 | 94.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
2.1 | 12.5 | GO:0071547 | piP-body(GO:0071547) |
2.0 | 16.3 | GO:0005869 | dynactin complex(GO:0005869) |
2.0 | 209.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.9 | 11.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
1.8 | 5.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
1.8 | 16.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.7 | 6.8 | GO:0044393 | microspike(GO:0044393) |
1.7 | 18.5 | GO:0030673 | axolemma(GO:0030673) |
1.7 | 16.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.6 | 8.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.6 | 3.3 | GO:0000322 | storage vacuole(GO:0000322) |
1.6 | 16.2 | GO:0008091 | spectrin(GO:0008091) |
1.6 | 22.5 | GO:0032426 | stereocilium tip(GO:0032426) |
1.6 | 23.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.6 | 4.7 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
1.5 | 10.7 | GO:0061617 | MICOS complex(GO:0061617) |
1.5 | 11.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.5 | 113.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.5 | 45.1 | GO:0005921 | gap junction(GO:0005921) |
1.4 | 4.3 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.4 | 7.0 | GO:0071203 | WASH complex(GO:0071203) |
1.4 | 5.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.4 | 9.7 | GO:0031045 | dense core granule(GO:0031045) |
1.3 | 15.8 | GO:0060091 | kinocilium(GO:0060091) |
1.3 | 67.0 | GO:0034704 | calcium channel complex(GO:0034704) |
1.3 | 14.2 | GO:0071564 | npBAF complex(GO:0071564) |
1.3 | 52.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.2 | 79.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
1.2 | 601.7 | GO:0098794 | postsynapse(GO:0098794) |
1.2 | 2.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
1.2 | 22.9 | GO:0044295 | axonal growth cone(GO:0044295) |
1.2 | 7.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.1 | 5.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.1 | 3.4 | GO:0005962 | mitochondrial isocitrate dehydrogenase complex (NAD+)(GO:0005962) isocitrate dehydrogenase complex (NAD+)(GO:0045242) |
1.1 | 5.5 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.1 | 7.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.1 | 5.5 | GO:0070695 | FHF complex(GO:0070695) |
1.0 | 5.2 | GO:0097452 | GAIT complex(GO:0097452) |
1.0 | 3.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.0 | 9.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.0 | 53.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.9 | 9.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.8 | 3.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.8 | 6.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.8 | 5.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.8 | 10.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.8 | 9.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.8 | 3.0 | GO:0035339 | SPOTS complex(GO:0035339) |
0.8 | 3.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.8 | 248.0 | GO:0045202 | synapse(GO:0045202) |
0.7 | 3.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.7 | 16.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.7 | 7.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.7 | 66.5 | GO:0030427 | site of polarized growth(GO:0030427) |
0.7 | 15.4 | GO:0019013 | viral nucleocapsid(GO:0019013) |
0.7 | 50.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.7 | 15.0 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.6 | 7.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.6 | 7.9 | GO:0000124 | SAGA complex(GO:0000124) |
0.6 | 7.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.6 | 11.7 | GO:0043679 | axon terminus(GO:0043679) |
0.6 | 3.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.6 | 1.7 | GO:0045025 | mitochondrial degradosome(GO:0045025) |
0.6 | 3.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.5 | 1.6 | GO:0042585 | germinal vesicle(GO:0042585) |
0.5 | 11.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.5 | 12.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.5 | 7.9 | GO:0036038 | MKS complex(GO:0036038) |
0.5 | 251.6 | GO:0043005 | neuron projection(GO:0043005) |
0.5 | 2.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.4 | 2.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 6.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.4 | 5.6 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 1.3 | GO:1990707 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
0.4 | 6.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.4 | 5.3 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.4 | 7.6 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 2.8 | GO:0045179 | apical cortex(GO:0045179) |
0.4 | 2.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.4 | 3.5 | GO:0033391 | chromatoid body(GO:0033391) |
0.4 | 4.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 5.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.4 | 2.2 | GO:0034464 | BBSome(GO:0034464) |
0.4 | 8.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 16.5 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 2.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 1.7 | GO:0034455 | t-UTP complex(GO:0034455) |
0.3 | 15.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 4.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 14.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 5.1 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.3 | 1.9 | GO:0044754 | autolysosome(GO:0044754) |
0.3 | 6.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 20.3 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.3 | 2.3 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 1.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 1.6 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 1.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 4.5 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 6.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 4.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 3.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 2.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 22.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 2.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 3.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 52.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 1.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 5.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 1.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 3.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.4 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 1.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 1.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 25.4 | GO:0030141 | secretory granule(GO:0030141) |
0.1 | 0.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.0 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 1.5 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.1 | 0.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 2.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 5.3 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 7.0 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 2.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 1.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.4 | GO:0016282 | eukaryotic 43S preinitiation complex(GO:0016282) eukaryotic 48S preinitiation complex(GO:0033290) |
0.0 | 0.3 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 2.5 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.8 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 2.0 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 1.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.2 | 66.6 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
21.1 | 63.2 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
17.2 | 103.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
13.6 | 81.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
11.0 | 66.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
10.9 | 43.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
10.6 | 74.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
9.6 | 28.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
9.2 | 55.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
8.7 | 26.2 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
8.6 | 25.8 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
8.0 | 32.0 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
7.9 | 31.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
7.6 | 61.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
7.5 | 22.4 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
7.4 | 29.6 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
7.3 | 29.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
7.1 | 49.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
6.8 | 33.9 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
6.7 | 26.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
6.7 | 46.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
6.5 | 19.6 | GO:0080130 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
6.5 | 149.9 | GO:0043274 | phospholipase binding(GO:0043274) |
6.3 | 25.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
6.3 | 25.1 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
6.2 | 87.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
6.1 | 18.4 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
6.1 | 72.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
6.0 | 24.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
6.0 | 18.0 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
5.9 | 23.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
5.9 | 23.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
5.3 | 21.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
5.1 | 20.5 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
5.0 | 15.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
5.0 | 15.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
4.9 | 48.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
4.8 | 14.5 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
4.8 | 19.2 | GO:0099609 | microtubule lateral binding(GO:0099609) |
4.7 | 23.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
4.7 | 33.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
4.7 | 61.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
4.7 | 23.5 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
4.6 | 18.5 | GO:0055100 | adiponectin binding(GO:0055100) |
4.3 | 42.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
4.2 | 29.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
4.1 | 20.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
4.0 | 72.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
3.9 | 19.6 | GO:0089720 | caspase binding(GO:0089720) |
3.8 | 26.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
3.8 | 26.5 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
3.7 | 52.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
3.7 | 11.0 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
3.6 | 43.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
3.5 | 10.5 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
3.5 | 59.2 | GO:0031402 | sodium ion binding(GO:0031402) |
3.5 | 10.4 | GO:0102390 | mycophenolic acid acyl-glucuronide esterase activity(GO:0102390) |
3.4 | 13.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
3.4 | 13.8 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
3.4 | 20.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
3.4 | 20.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
3.3 | 9.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
3.1 | 9.2 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
3.1 | 12.2 | GO:0008489 | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity(GO:0008489) |
3.0 | 11.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
2.9 | 38.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
2.9 | 20.3 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.9 | 17.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
2.8 | 28.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
2.7 | 46.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
2.7 | 76.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
2.7 | 13.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
2.6 | 21.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
2.6 | 21.0 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
2.6 | 18.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
2.6 | 10.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
2.6 | 141.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
2.5 | 10.2 | GO:0034584 | piRNA binding(GO:0034584) |
2.5 | 9.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
2.4 | 23.5 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
2.3 | 21.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
2.3 | 13.8 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
2.3 | 4.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
2.2 | 17.8 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
2.2 | 20.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
2.2 | 143.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
2.2 | 6.5 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
2.1 | 10.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
2.1 | 10.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.1 | 16.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
2.1 | 20.6 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
2.1 | 8.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.1 | 8.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
2.0 | 24.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
2.0 | 4.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.0 | 8.0 | GO:0043495 | protein anchor(GO:0043495) |
1.9 | 62.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
1.9 | 9.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.9 | 7.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.8 | 7.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.8 | 16.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.8 | 7.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.8 | 10.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
1.8 | 7.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
1.7 | 12.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
1.7 | 46.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.7 | 20.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
1.6 | 4.9 | GO:0052724 | inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.6 | 9.7 | GO:0070061 | fructose binding(GO:0070061) |
1.6 | 4.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.6 | 6.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.6 | 9.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
1.6 | 103.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.6 | 7.8 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) dopamine:sodium symporter activity(GO:0005330) |
1.5 | 15.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
1.5 | 16.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.5 | 6.0 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
1.5 | 3.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
1.5 | 17.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.5 | 4.4 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
1.5 | 58.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.4 | 5.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.4 | 22.7 | GO:0035198 | miRNA binding(GO:0035198) |
1.4 | 11.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.4 | 9.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.3 | 5.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.3 | 6.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.3 | 5.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.3 | 21.4 | GO:0016918 | retinal binding(GO:0016918) |
1.3 | 8.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.3 | 19.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.3 | 4.0 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
1.3 | 5.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.3 | 2.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.3 | 37.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
1.3 | 32.0 | GO:0030552 | cAMP binding(GO:0030552) |
1.3 | 21.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.2 | 16.1 | GO:0008061 | chitin binding(GO:0008061) |
1.2 | 11.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
1.2 | 22.1 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
1.2 | 7.3 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
1.2 | 6.0 | GO:0015142 | tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.2 | 4.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.2 | 7.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) GPI anchor binding(GO:0034235) |
1.2 | 10.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
1.2 | 3.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.2 | 8.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
1.2 | 31.2 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
1.1 | 9.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
1.1 | 4.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.1 | 13.6 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
1.1 | 7.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.1 | 21.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
1.1 | 36.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.1 | 32.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
1.1 | 5.5 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.1 | 10.9 | GO:0004526 | ribonuclease P activity(GO:0004526) |
1.1 | 8.6 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
1.1 | 5.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.1 | 7.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.1 | 3.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.0 | 4.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
1.0 | 13.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.0 | 7.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.0 | 3.0 | GO:0016403 | dimethylargininase activity(GO:0016403) |
1.0 | 11.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.0 | 7.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.0 | 6.7 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.0 | 11.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.9 | 17.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.9 | 2.8 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.9 | 45.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.9 | 4.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.9 | 5.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.9 | 22.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.9 | 5.5 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.9 | 5.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.9 | 11.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.9 | 42.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.9 | 4.4 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.9 | 26.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.9 | 16.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.8 | 3.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.8 | 32.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.8 | 15.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.8 | 5.0 | GO:0071253 | connexin binding(GO:0071253) |
0.8 | 12.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.8 | 5.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.8 | 10.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.8 | 17.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.8 | 3.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.7 | 7.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.7 | 6.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.7 | 2.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.7 | 2.1 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
0.7 | 70.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.7 | 12.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.7 | 2.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.7 | 5.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.7 | 9.7 | GO:0051378 | serotonin binding(GO:0051378) |
0.7 | 2.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.7 | 2.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.6 | 9.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.6 | 4.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.6 | 2.6 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) G-protein coupled neurotensin receptor activity(GO:0016492) |
0.6 | 17.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.6 | 3.8 | GO:0017040 | ceramidase activity(GO:0017040) |
0.6 | 3.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.6 | 21.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.6 | 3.1 | GO:0001155 | TFIIIA-class transcription factor binding(GO:0001155) |
0.6 | 3.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.6 | 5.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.6 | 2.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.6 | 7.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.6 | 12.9 | GO:0070840 | dynein complex binding(GO:0070840) |
0.6 | 7.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.6 | 4.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.6 | 4.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.6 | 15.9 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.6 | 12.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.5 | 15.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.5 | 8.7 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.5 | 9.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.5 | 3.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.5 | 3.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.5 | 8.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.5 | 1.6 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.5 | 6.3 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.5 | 6.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.5 | 2.1 | GO:0035673 | lipid-transporting ATPase activity(GO:0034040) oligopeptide transmembrane transporter activity(GO:0035673) |
0.5 | 6.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 5.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.5 | 2.6 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.5 | 1.5 | GO:0008254 | 3'-nucleotidase activity(GO:0008254) |
0.5 | 5.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 14.8 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.5 | 6.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.5 | 7.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.5 | 1.4 | GO:0004058 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.5 | 8.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 1.4 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.5 | 0.9 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.5 | 1.4 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.5 | 1.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.5 | 2.7 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.5 | 3.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.5 | 4.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.5 | 2.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.5 | 1.4 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.4 | 3.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.4 | 7.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.4 | 2.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.4 | 1.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 3.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.4 | 2.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.4 | 6.1 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 7.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.4 | 1.2 | GO:0032564 | dATP binding(GO:0032564) |
0.4 | 5.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 10.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.4 | 208.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.4 | 5.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.4 | 6.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 6.0 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.4 | 8.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.4 | 9.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.4 | 16.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 6.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.4 | 90.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.4 | 6.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.4 | 6.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.4 | 24.3 | GO:0044325 | ion channel binding(GO:0044325) |
0.4 | 1.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.4 | 1.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 12.7 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.3 | 5.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.3 | 14.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 3.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 72.8 | GO:0015631 | tubulin binding(GO:0015631) |
0.3 | 1.3 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.3 | 32.3 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 4.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 30.9 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.3 | 1.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 0.9 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.3 | 1.5 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.3 | 7.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 6.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 1.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 9.2 | GO:0009055 | electron carrier activity(GO:0009055) |
0.3 | 1.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 0.8 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.3 | 1.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.3 | 1.8 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 4.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 4.4 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 7.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 4.0 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 0.6 | GO:0004825 | methionine-tRNA ligase activity(GO:0004825) |
0.2 | 0.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 1.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 1.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 2.0 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) NAD-dependent protein deacetylase activity(GO:0034979) |
0.2 | 0.8 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 2.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 1.7 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 1.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.5 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.2 | 1.0 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 1.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.2 | 4.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 1.6 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 2.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 2.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 28.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 12.0 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 1.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 9.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 1.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 1.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.8 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 3.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 1.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 2.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 2.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 1.6 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 1.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 4.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 1.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 27.2 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 2.4 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 1.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 47.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.0 | 1.3 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 0.8 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 1.3 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 134.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
3.0 | 66.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
2.8 | 147.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.6 | 37.3 | ST ADRENERGIC | Adrenergic Pathway |
1.5 | 19.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.4 | 7.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.3 | 5.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.2 | 20.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
1.2 | 10.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.1 | 32.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.0 | 42.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.0 | 23.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.0 | 2.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.0 | 25.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.0 | 16.6 | PID IGF1 PATHWAY | IGF1 pathway |
1.0 | 20.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.0 | 9.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.0 | 20.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.9 | 14.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.9 | 36.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.9 | 49.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.9 | 10.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.9 | 30.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.8 | 20.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.7 | 9.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.6 | 28.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.6 | 11.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.6 | 14.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.6 | 9.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 19.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.5 | 22.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 4.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 6.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.4 | 87.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.4 | 4.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 7.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 19.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 2.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 4.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 6.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 4.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 3.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 1.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 4.6 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 1.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 3.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 3.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.6 | 155.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
8.0 | 71.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
3.6 | 61.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
3.3 | 19.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
3.0 | 60.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
3.0 | 65.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
2.8 | 50.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
2.8 | 78.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.7 | 35.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
2.6 | 49.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
2.5 | 22.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
2.4 | 29.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
2.4 | 38.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
2.3 | 31.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
2.2 | 6.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
2.1 | 39.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
2.1 | 37.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
2.0 | 30.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
2.0 | 22.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
2.0 | 19.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.9 | 41.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
1.8 | 30.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.8 | 28.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.6 | 25.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.6 | 23.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.6 | 44.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.6 | 26.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.5 | 20.1 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
1.5 | 50.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.5 | 47.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.4 | 22.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.4 | 40.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.4 | 31.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
1.3 | 66.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.3 | 11.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
1.3 | 17.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.2 | 19.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
1.0 | 23.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.0 | 16.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
1.0 | 17.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.9 | 166.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.9 | 11.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.9 | 23.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.9 | 9.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.9 | 68.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.9 | 25.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.8 | 13.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.8 | 9.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.8 | 6.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 13.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.7 | 20.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.7 | 11.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.7 | 18.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.7 | 11.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.7 | 23.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.7 | 8.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.6 | 8.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.6 | 26.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.6 | 25.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.6 | 2.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.6 | 12.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 6.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.5 | 15.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.5 | 7.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.5 | 8.0 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.5 | 4.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 6.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 13.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.5 | 1.9 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.4 | 17.3 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.4 | 4.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.4 | 3.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 10.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 19.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.4 | 9.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 12.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 2.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 11.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 7.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 3.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 4.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 4.1 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 14.8 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.2 | 2.7 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 4.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 0.9 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 2.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 5.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 1.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |